Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report)’s share price was up 3.1% during mid-day trading on Friday after Truist Financial raised their price target on the stock from $6.00 to $9.00. Truist Financial currently has a buy rating on the stock. Autolus Therapeutics traded as high as $3.08 and last traded at $3.03. Approximately […]
Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) saw a large growth in short interest in the month of July. As of July 15th, there was short interest totalling 1,580,000 shares, a growth of 6.0% from the June 30th total of 1,490,000 shares. Based on an average trading volume of 707,000 shares, the days-to-cover ratio […]
Autolus Therapeutics plc (NASDAQ:AUTL – Get Rating) saw a significant decrease in short interest in May. As of May 15th, there was short interest totalling 739,700 shares, a decrease of 14.1% from the April 30th total of 861,000 shares. Based on an average daily trading volume, of 573,600 shares, the days-to-cover ratio is currently 1.3 […]
Autolus Therapeutics plc (NASDAQ:AUTL – Get Rating) shares saw strong trading volume on Wednesday . 610,756 shares were traded during mid-day trading, an increase of 2% from the previous session’s volume of 600,028 shares.The stock last traded at $2.90 and had previously closed at $3.19. Analysts Set New Price Targets Several analysts have recently commented […]
Autolus Therapeutics (NASDAQ:AUTL – Get Rating) and Seagen (NASDAQ:SGEN – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, earnings, institutional ownership and profitability. Insider and Institutional Ownership 70.1% of Autolus Therapeutics shares are owned […]